Metropolitan Life Insurance Company (MetLife)’s Cascadian Therapeutics, Inc. CASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | – | Sell |
-12,324
| Closed | -$164K | – | 2555 |
|
|
2015
Q4 | $164K | Hold |
12,324
| – | – | ﹤0.01% | 2385 |
|
|
2015
Q3 | $203K | Buy |
12,324
+5,979
| +94% | +$98.5K | ﹤0.01% | 2270 |
|
|
2015
Q2 | $142K | Buy |
+6,345
| New | +$142K | ﹤0.01% | 2556 |
|
|
2014
Q3 | – | Sell |
-9,720
| Closed | -$189K | – | 2774 |
|
|
2014
Q2 | $189K | Buy |
+9,720
| New | +$189K | ﹤0.01% | 2554 |
|